[1]
Mokkarala, R.R. and Badugu, J.P. 2022. Evaluation of dexmedetomidine as adjuvant to 0.5% ropivacaine in comparison to dexamethasone in supraclavicular block. International Journal of Clinical Trials. 9, 2 (Apr. 2022), 89–93. DOI:https://doi.org/10.18203/2349-3259.ijct20221107.